BRLI Financial Facts

Bad Debt Expense: 19.65M
Depreciation and Amortization: 1.61M
See Full Income Statement

Capital Lease Obligations - Long-Term Portion: 10.86M
Current Maturities of Long-Term Debt: 541K
See Full Balance Sheet

Bio-Reference Laboratories Inc. (BRLI) Earnings

  |   Expand Research on BRLI
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -7.5% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -1.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
12/19/13 Q413 $0.40$0.55 -$0.15$192.22M$188.96M N/A Details
3/4/14 Q114 N/A$0.15 N/A N/A$175.52M N/A N/A N/A
3/5/15 Q115 $0.24$0.32 -$0.08$209M$216.4M N/A Details
6/8/15 Q215 $0.38$0.44 -$0.06$224M$231.87M N/A Details
6/5/13 Q213 $0.41$0.41 $0.00$176.5M$176.04M N/A Details
12/6/12 Q412 $0.46$0.46 $0.00$176.05M$175.46M N/A Details
5/26/11 Q211 $0.26$0.25 +$0.01$137.7M$131.2M N/A Details
6/7/12 Q212 $0.33$0.32 +$0.01$163.4M$161.48M N/A Details